CRISPR/Cas9-Advancing Orthopoxvirus Genome Editing for Vaccine and Vector Development

Area of Science:

• Molecular Biology
• Virology
• Biotechnology

Background:

• CRISPR/Cas9 technology offers efficient, specific, and versatile genome editing.
• It is superior to TALENs and ZFNs for virus genome editing.
• Current applications include constructing viral mutants and inhibiting viral replication.

Purpose of the Study:

• To review CRISPR/Cas9 applications in virus genome editing.
• To discuss CRISPR/Cas9's potential in advancing orthopoxvirus (OPXV)-based vaccines and vectors.
• To explore CRISPR/Cas9's role in combating clinical viruses and its limitations.

Main Methods:

• Literature review of CRISPR/Cas9 applications in virus genome editing.
• Analysis of CRISPR/Cas9's utility in orthopoxvirus (OPXV) genome manipulation.
• Discussion of current limitations and strategies for CRISPR/Cas9 optimization.

Main Results:

• CRISPR/Cas9 successfully adapted for Vaccinia virus genome editing.
• Potential for CRISPR/Cas9 in editing other OPXV strains for vaccine development.
• CRISPR/Cas9 addresses hindrances like immunogenicity, instability, and biosafety concerns.

Conclusions:

• CRISPR/Cas9 is a revolutionary tool for virus genome editing.
• It holds significant promise for developing improved OPXV-based recombinant vaccines and vectors.
• Further research and strategies are needed to overcome CRISPR/Cas9 limitations.